VITROLIFE AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 186.6 SEK | -2.30% |
|
+0.21% | -4.16% |
| Mar. 18 | Memphasys Secures Additional Order for Fertility Device System in Japan; Shares Jump 9% | MT |
| Feb. 05 | Nordic Shares Rose Monday; Vitrolife Topped Leaders | DJ |
Chart calendar Vitrolife AB
d208b37ea3559029eb417.ND8HRhbhs76JfkEu1N4rQKzACf5hfeYx5D-HrRd_L-c.fQtuA0_S4c_mMS5cmZdSOP2uR5wtD5YJh0_r_mA4GaF6TFI2fIL67LwIIg~403b308b880f2308c89423c19013a612
Upcoming events on Vitrolife AB
Past events on Vitrolife AB
| 2024-02-02 04:00 am | Q4 2023 Earnings Call |
| 2024-02-02 02:17 am | Q4 2023 Earnings Release |
| 2023-12-12 04:00 am | Capital Markets Day |
| 2023-10-27 04:00 am | Q3 2023 Earnings Call |
| 2023-10-27 02:00 am | Q3 2023 Earnings Release |
| 2023-07-14 04:00 am | Q2 2023 Earnings Call |
| 2023-07-14 02:00 am | Q2 2023 Earnings Release |
| 2023-04-27 | Ex-dividend day for final dividend |
| 2023-04-27 10:00 am | Annual General Meeting |
| 2023-04-21 04:00 am | Q1 2023 Earnings Call |
| 2023-04-21 02:08 am | Q1 2023 Earnings Release |
| 2023-02-02 04:00 am | FY 2022 Earnings Call |
| 2023-02-02 02:24 am | FY 2022 Earnings Release |
| 2022-10-27 04:00 am | Q3 2022 Earnings Call |
| 2022-10-27 02:27 am | Q3 2022 Earnings Release |
| 2022-07-15 04:00 am | Interim 2022 Earnings Call |
| 2022-07-15 02:00 am | Interim 2022 Earnings Release |
| 2022-04-27 | Ex-dividend day for final dividend |
| 2022-04-27 10:00 am | Annual General Meeting |
| 2022-04-22 04:00 am | Q1 2022 Earnings Call |
Past dividends on Vitrolife AB
| 2023-04-27 | Annual 0.85 SEK |
| 2022-04-27 | Annual 0.8 SEK |
| 2021-04-28 | Annual 0.8 SEK |
| 2019-05-02 | Annual 0.85 SEK |
| 2018-04-26 | Annual 3.7 SEK |
| 2017-04-27 | Annual 2.6 SEK |
| 2016-04-28 | Annual 2.4 SEK |
| 2015-05-05 | Annual 1.5 SEK |
| 2014-05-05 | Annual 1 SEK |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 1 151 1 136 1.35% | 1 480 1 472 0.56% | 1 246 1 248 -0.19% | 1 681 1 690 -0.53% | 3 234 3 208 0.81% | 3 512 3 498 0.41% |
|
EBITDA Million SEK | Released Forecast Spread | 479 465 3.06% | 587 589 -0.32% | 454 446 1.91% | 645 629 2.56% | 1 050 1 054 -0.37% | 1 136 1 133 0.23% |
|
EBIT Million SEK | Released Forecast Spread | 394 396 -0.61% | 488 494 -1.13% | 370 351 5.29% | 536 530 1.27% | 654 670 -2.42% | -3 589 711 -604.76% |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 399 396 0.73% | 493 507 -2.88% | 366 358 2.33% | 460 527 -12.8% | 537 597 -10.11% | -3 712 581 -739.1% |
|
Net income Million SEK | Released Forecast Spread | 310 307 0.92% | 383 394 -2.76% | 288 279 3.08% | 341 410 -16.76% | 394 448 -12.11% | -3 851 456 -944.14% |
|
EPS SEK | Released Forecast Spread | 2,85 2,83 0.65% | 3,53 3,60 -1.92% | 2,64 2,57 2.62% | 2,97 3,21 -7.41% | 2,91 3,31 -12.08% | -28,4 3,37 -944.42% |
| Announcement Date | 08/02/19 | 06/02/20 | 10/02/21 | 16/02/22 | 02/02/23 | 02/02/24 |
Quarterly results
| Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 406 387 5% | 514 524 -1.81% | 752 746 0.77% | 829 774 7.1% | 798 788 1.27% | 855 834 2.47% | 854 834 2.34% | 905 920 -1.62% | 848 884 -4.12% | 904 891 1.47% | 880 | 961 | 922 | 989 |
|
EBITDA Million SEK | Released Forecast Spread | 162 140 15.49% | 164 130 26.15% | 228 246 -7.32% | 273 246 10.79% | 276 254 8.69% | 273 276 -0.97% | 262 286 -8.38% | 293 304 -3.67% | 287 289 -0.62% | 294 293 0.34% | 285 | 326 | 310 | 329 |
|
EBIT Million SEK | Released Forecast Spread | 142 122 16.23% | 119 134 -11.25% | 133 160 -16.62% | 175 151 15.96% | 177 162 9.3% | 168 180 -6.5% | 159 183 -13.19% | 188 200 -5.77% | 179 183 -2.35% | -4 115 185 -2324.97% | 177 | 217 | 199 | 219 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 141 95,0 48.21% | 61,3 83,0 -26.13% | 113 148 -23.39% | 169 135 25.26% | 149 146 2.35% | 106 157 -32.34% | 130 148 -12.11% | 135 182 -25.72% | 152 146 4.39% | -4 130 150 -2861.25% | 147 | 198 | 183 | 208 |
|
Net income Million SEK | Released Forecast Spread | 105 106 -0.94% | 32,6 65,0 -49.81% | 82,0 115 -28.6% | 130 102 27.76% | 108 119 -8.95% | 74,0 120 -38.52% | 100 112 -11.04% | 106 138 -23.11% | 122 111 10.25% | -4 179 115 -3730.11% | 113 | 152 | 140 | 160 |
|
EPS SEK | Released Forecast Spread | 0,89 0,67 33.83% | 0,26 0,48 -45.83% | 0,60 1,50 -60% | 0,96 0,39 149.35% | 0,80 0,58 37.24% | 0,55 0,43 29.41% | 0,78 1,02 -23.53% | 0,90 | -30,9 0,83 -3818.07% | |||||
| Announcement Date | 29/10/21 | 16/02/22 | 22/04/22 | 15/07/22 | 27/10/22 | 02/02/23 | 21/04/23 | 14/07/23 | 27/10/23 | 02/02/24 | - | - | - | - |
More events
Past sector events for Vitrolife AB
| Today | AMOY DIAGNOSTICS CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-11 | SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-09 01:00 am | BIOMÉRIEUX: Q1 2024 Sales and Revenue Release |
| 2024-03-29 | BEIJING STRONG BIOTECHNOLOGIES,INC.: Q4 2023 Earnings Release |
| 2024-03-27 | NEW HORIZON HEALTH LIMITED: Q4 2023 Earnings Release |
| 2024-03-27 02:30 am | SD BIOSENSOR, INC: Q4 2023 Earnings Release |
| 2024-03-22 | SHANGHAI KEHUA BIO-ENGINEERING CO.,LTD: Q4 2023 Earnings Release |
| 2024-03-21 | SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD.: Q4 2023 Earnings Release |
| 2024-03-15 08:35 am | DIASORIN S.P.A.: Q4 2023 Earnings Release |
| 2024-03-14 02:00 am | BIOMÉRIEUX: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VITR Stock
- Calendar Vitrolife AB
